Neogenomics (NEO) Cash from Investing Activities Growth (3y) (2013 - 2026)
Neogenomics (NEO) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -186.61% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -49.54% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 13.86% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 2.46% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 64.36% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -13.03% |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | -36.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36.74% |
| Mar 31, 2026 | -30.27% |
| Dec 31, 2025 | -81.02% |
| Sep 30, 2025 | 59.59% |
| Jun 30, 2025 | -14.08% |
| Mar 31, 2025 | -33.40% |
| Dec 31, 2024 | 17.06% |
| Sep 30, 2024 | 37.91% |
| Jun 30, 2024 | 26.33% |
| Mar 31, 2024 | 27.93% |
| Dec 31, 2023 | 37.44% |
| Sep 30, 2023 | 31.89% |
| Jun 30, 2023 | 41.33% |
| Mar 31, 2023 | 36.96% |
| Dec 31, 2022 | 44.07% |
| Sep 30, 2022 | 16.90% |
| Jun 30, 2022 | -27.29% |
| Mar 31, 2022 | 79.37% |
| Dec 31, 2021 | 57.92% |
| Sep 30, 2021 | -89.80% |